TITLE

2010 - Use of bisphosphonates was not associated with increased risk for esophageal or gastric cancer

AUTHOR(S)
Lim, Lionel S.
PUB. DATE
December 2010
SOURCE
ACP Journal Club;12/21/2010, Vol. 153 Issue 6, p11
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on a study examining whether exposure to oral bisphosphonates is associated with increased risk for esophageal cancer. The study revealed that oral bisphosphonates are highly effective for treating osteoporosis and preventing fractures and their use was not associated with increased risk for esophageal or gastric cancer.
ACCESSION #
63022520

 

Related Articles

  • Incidence of Stomach Cancer in Oman and the Other Gulf Cooperation Council Countries. Al-Mahrouqi, Haitham; Parkin, Lianne; Sharples, Katrina // Oman Medical Journal;Jul2011, Vol. 26 Issue 4, p258 

    Objectives: Stomach cancer is the most common cancer among males in Oman and the second most frequent among females from 1997 to 2007. Reports have suggested the rate is higher in Oman than in the other GCC countries. This study aims to describe the epidemiology of stomach cancer in Oman and to...

  • Population Attributable Fractions of Adenocarcinoma of the Esophagus and Gastroesophageal Junction. Olsen, Catherine M.; Pandeya, Nirmala; Green, Adèle C.; Webb, Penelope M.; Whiteman, David C. // American Journal of Epidemiology;Sep2011, Vol. 174 Issue 5, p582 

    Obesity, gastroesophageal reflux, and smoking have repeatedly been shown to be important and independent risk factors for adenocarcinoma of the esophagus (EAC) and of the gastroesophageal junction (GEJAC). There have been few attempts, however, to quantify the proportion of disease associated...

  • Multiple esophagogastric granular cell tumors. Maekawa, Hiroshi; Maekawa, Takeo; Yabuki, Kiyotaka; Sato, Kouichi; Tamazaki, Yoshihisa; Kudo, Keizou; Wada, Ryo; Matsumoto, Michio // Journal of Gastroenterology;2003, Vol. 38 Issue 8, p776 

    Multiple granular cell tumors of the esophagus and the stomach found in a 53-year-old man are reported. One lesion was detected within the lower thoracic esophagus and seven lesions were detected in the stomach. The esophageal tumor was resected endoscopically, and gastrectomy was performed for...

  • Survival rates for patients with oesophageal and stomach cancer improve.  // Gastrointestinal Nursing;Jul2012, Vol. 10 Issue 6, p6 

    The article notes that the National Oesophago-Gastric Cancer Audit found an increase in survival rates of oesophageal and stomach cancers due to better organisation of NHS cancer services in England and Wales. Nearly 45-50 percent of patients with oesophageal and stomach cancer live for 3 years...

  • Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study. Sambrook, P.; Cameron, I.; Chen, J.; March, L.; Simpson, J.; Cumming, R.; Seibel, M. // Osteoporosis International;Sep2011, Vol. 22 Issue 9, p2551 

    Summary: In a study of 2005 institutionalized older people, use of oral bisphosphonates was associated with a 27% reduction in risk of death compared to non-users after adjusting for potential confounders. Introduction: This study investigated whether reductions in mortality reported in a trial...

  • Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia // BMJ: British Medical Journal;2/9/2013, Vol. 346 Issue 7894, p14 

    The article discusses whether bisphosphonates used for the treatment of osteoporosis are associated with increased risks of oesophageal, gastric, or colorectal cancers. It is revealed that bisphosphonates use in general is not associated with increased risks for any common gastrointestinal...

  • Many oesophageal and gastric cancers are detected too late. Kmietowicz, Zosia // BMJ: British Medical Journal;12/6/2014, Vol. 349 Issue 7896, pg7340 

    The article reports on an oesophagogastric cancer audit in Great Britain in 2014 which revealed the increase in the number of patients surviving surgery for oesophageal and stomach cancer.

  • Long-term use of oral bisphosphonates increases the risk of oesophageal but not gastric or colorectal cancer. Etminan, Mahyar // Evidence Based Medicine;Feb2011, Vol. 16 Issue 1, p28 

    A review is presented of the article "Oral Bisphosphonates and Risk of Cancer of Oesophagus, Stomach, and Colorectum: Case-Control Analysis Within a UK Primary Care Cohort" by J. Green et al., which appeared in a 2010 issue of the "British Medical Journal".

  • Clinical digest. Continued care after surgery benefits patients with gastric or oesophageal cancer.  // Nursing Standard;2/6/2013, Vol. 27 Issue 23, p15 

    The article discusses research which was reported in the article "Long-Term Experiences After Oesphagectomy/Gastrectomy for Cancer: A Focus Group Study" by M. Malmstrom et al. and found that continued care after surgery benefits patients with gastric or oesophageal cancer.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics